CALCIUM WITH ERGOCALCIFEROL is a brand name for Calcium Phosphate. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: For the treatment of calcium and vitamin D deficiency.
Verbatim from this product's MHRA label. Tap a section to expand.
Posology Adults Normal deficiency:
One tablet daily.
Severe deficiency:
Higher doses may be necessary, as directed by the physician. The elderly Do not use in the elderly without medical advice.
Children Over 12 years of age:
As directed by the physician.
Under 12 years of age:
Not recommended. Method of administration Oral.
Undesirable effects are more likely if larger than recommended doses are taken, if taken for a longer period of time or if taken by patients with renal function impairment. The following are undesirable effects with frequency unknown (cannot be estimated from the available data): Hypercalcaemia may occur.
Constipation, drowsiness, headache, loss of appetite, unusually dry mouth, tiredness or weakness are early signs of hypercalcaemia. Additional effects of either calcium or ergocalciferol can be abdominal pain, constipation, diarrhoea, nausea, vomiting, weight loss, hypercalciuria, arrhythmia, asthenia, myalgia.
Reporting of suspected adverse reactions:
Reporting suspected adverse reactions after authorisation of the medicinal product is important. It allows continued monitoring of the benefit/risk balance of the medicinal product. uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store
Risk-benefit should be considered in the following medical conditions: dehydration, electrolyte imbalance, diarrhoea or chronic gastro-intestinal malabsorption. Hypercalcaemic effect should be borne in mind when prescribing these tablets and the role of the liver and kidney on the different forms of vitamin D.
Plasma-calcium concentrations should be monitored at intervals and whenever nausea or vomiting occurs, or in renal impairment and in patients receiving high doses. Patients with rare hereditary problems of galactose intolerance, total lactase deficiency or glucose-galactose malabsorption should not take this medicine.
1. Hypercalcaemia, hypercalciuria, renal calculi, renal function impairment, sarcoidosis, hypoparathyroidism and metastatic calcification.
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Know a brand we are missing in United Kingdom? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.